Peramivir Market was valued at USD 0.25 Billion in 2022 and is projected to reach USD 0.35 Billion by 2030, growing at a CAGR of 5.0% from 2024 to 2030.
The market outlook during these years was also influenced by a broader shift toward more targeted therapies, with Peramivir standing out for its efficiency and rapid action. Its approval in multiple regions such as the US, Europe, and Asia further fueled its accessibility. Moreover, pharmaceutical companies focused on improving drug formulations, increasing market competition and thereby enhancing the overall availability and affordability of Peramivir. The expansion of healthcare infrastructure, along with government support for antiviral treatments, contributed significantly to this growth trajectory. Looking ahead from 2023 to 2033, the Peramivir market is expected to see a shift in demand dynamics, with potential changes due to the evolving nature of infectious diseases and ongoing healthcare priorities. While the demand for traditional antiviral drugs like Peramivir remains relevant, the growing focus on personalized medicine and advancements in biotechnology might lead to more sophisticated alternatives. Additionally, the possibility of new strains of viruses and the lingering concerns about pandemics might prompt healthcare professionals to rely on proven treatments such as Peramivir. The post-2022 landscape is likely to witness ongoing research into optimizing Peramivir's effectiveness and broadening its application in combination therapies. Although the demand for Peramivir might experience fluctuations based on these factors, its role in the global antiviral drug market remains vital. Factors such as regional healthcare policies, vaccination progress, and the management of influenza outbreaks will continue to influence the market's growth trajectory.
Get an In-Depth Research Analysis of the Global Peramivir Market Size And Forecast [2025-2032]
In the period from 2018 to 2022, the Peramivir market experienced significant growth, primarily driven by increased demand for antiviral drugs amid the global health crises. Peramivir, a neuraminidase inhibitor, was mainly used for the treatment of influenza, which pushed its adoption in the medical community. The rise in seasonal flu outbreaks and the heightened awareness of respiratory viruses during this period contributed to the growing market size. The drug's effectiveness against various strains of the influenza virus and its ability to reduce symptoms and shorten the duration of illness led to widespread use in hospitals and healthcare settings.
BioCryst Pharmaceuticals
Green Cross Pharma
Shionogi Co.
NeoPharm
Moksha8 Pharma
NT Pharma
Merck
Hikma Pharmaceuticals
Hunan Nucien Pharmaceutical Co.
Ltd.
SCOLR Pharma
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Peramivir Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Peramivir Market
Influenza A Treatment
Influenza B Treatment
Based on Types the Market is categorized into Below types that held the largest Peramivir market share In 2023.
Solution
Solid
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Peramivir Market Research Analysis
1. Introduction of the Global Peramivir Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Peramivir Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Peramivir Market, By Type
6. Global Peramivir Market, By Application
7. Global Peramivir Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Peramivir Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/